In early April, President Donald Trump gathered dozens of hard-hat-clad coal miners around him in the White House East Room.

Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG ...

The global Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and reach USD 682.9 ...

(Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger adjusted quarterly profit on Thursday, ...

They stated, Cipla’s sales/volume market share in Lanreotide injection at 13%/16% in March 2025. The pharma major recorded marginal improvement QoQ. The company expects supplies to be restored ...

JB Chemicals & Pharmaceutical marked a growth of 17.1% YoY, while Cipla Ltd saw sales grow 16.3% YoY. Ipca Laboratories on the other hand marked a growth of 14.3% YoY. All these firms recorded ...

Cipla Q4FY25 Results Preview: Strong show seen with margin boost; US biz, gRevlimid key triggers Pharma stocks under pressure: Sun Pharma cracks 5%, Nifty Pharma down 2% after Trump’s big blow on US ...

Shares of Cipla, Sun Pharmaceutical Industries, Bajaj Auto, HCL Technologies, Tech Mahindra hit their fresh 52 wk highs today. Nifty 50 was down by -0.6(0.0%) points and Sensex was up by 53.27(0. ...

Japan's Takeda Pharmaceutical (4502.T), opens new tab gave India's Sun Pharmaceutical (SUN.NS), opens new tab and Cipla (CIPL.NS), opens new tab the rights to commercialize gastrointestinal drug ...

Cipla shares surged 2.5 percent in trade on March 11 to touch a fresh lifetime high of Rs 1,519 apiece, extending its rally. So far, in 2024, shares of the pharma major have jumped over 20 ...